Syra Health Corp. Class A Common Stock (SYRA): fair value, margin of safety and Wheel Score

Is SYRA undervalued?

Syra Health Corp. Class A Common Stock (SYRA) closed at 0.8430 on 16 Oct 2026, 274% above the GLS average fair value of 0.2255. 7 of the 7 models that produced a number value the shares below the current price. A gap this wide usually means the market is paying for growth or a story the trailing numbers do not show yet; the models work from filed results, not forecasts, so they are conservative by design.

There is a wide gap between EPV (0.1103) and Graham Growth (0.4985). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files SYRA under Blend.

Nine valuation models for SYRA

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

Quality and financial health

Syra Health Corp. Class A Common Stock scores 5 of 9 on the Piotroski F-score: a middling result that falls one point short of the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. A GLS Moat score of 1.6/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are thin or negative - ROIC -40.0%, ROE -42.7%, ROA -32.3% - with debt at 0.07 times equity and a free-cash-flow yield of 1.1%.

Syra Health Corp. Class A Common Stock pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Population Health 100% (quarter Q2 FY2026).

Institutional ownership scores 5/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Wheel Score 14: No options

No options are listed on Syra Health Corp. Class A Common Stock in our nightly snapshot. The Wheel Score is therefore capped at 39 (it reads 14) and the stock is left out of every options screen; the fair value and health figures above are still useful for a plain stock position.

Volume runs at 5k shares a day on a market cap of $10M, with a beta of 3.37 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score gives that 0 of 20.

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

The next earnings report is due on 18 Nov 2026 (before the open), 33 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Medical - Care Facilities

The 12 companies below are the closest to Syra Health Corp. Class A Common Stock by market cap within the Medical - Care Facilities industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

⚖ Compare SYRA with 7 of them   All Healthcare stocks →